Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 14, 2025; 31(6): 101163
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.101163
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.101163
Table 1 Pretreatment baseline data of patients in both groups (measured data)
Variable | PC group (n = 54) | Conservative group (n = 29) | t/z value | P value |
Age (years) | 62.7 ± 20.63 | 55.55 ± 15.92 | 1.624 | 0.108 |
BMI | 25.31 ± 3.34 | 24.62 ± 2.47 | 0.983 | 0.329 |
Hospitalization (days) | 17.28 ± 9.72 | 15.9 ± 4.36 | 0.726 | 0.47 |
Temperature (°C) | 37.5 (36.8-38.18) | 37.8 (37.3-38.5) | -0.513 | 0.130 |
WBC (× 109/L) | 13.6 (10.87-16.62) | 12.6 (8.95-16.73) | -0.817 | 0.414 |
NEU (%) | 88.2 (82.8-90.9) | 85.1 (78.6-88.95) | -1.662 | 0.097 |
ALT (U/L) | 49 (24.68-100.45) | 35.9 (28.5-48.9) | -1.027 | 0.305 |
GGT (U/L) | 106.5 (51.5-238) | 71 (52.5-126.5) | -1.141 | 0.254 |
TBIL (μmol/L) | 29.35 (17.57-54) | 22.2 (17.4-29.5) | -1.944 | 0.052 |
DBIL (μmol/L) | 2.75 (0-12.95) | 0 (0-4.65) | -1.562 | 0.118 |
IBIL (μmol/L) | 13.9 (8.58-27) | 11.7 (8.7-13.4) | -1.829 | 0.067 |
AMS (U/L) | 394.5 (151.25-1060) | 211 (101.5-650) | -1.705 | 0.088 |
CTSI | 3 (3-5) | 3 (3-3) | -0.282 | 0.778 |
- Citation: Yan X, Xie F, Zhao XD, Li L, Meng JX. Short-term efficacy of early percutaneous cholecystostomy for pancreatitis and factors associated with recurrence and mortality. World J Gastroenterol 2025; 31(6): 101163
- URL: https://www.wjgnet.com/1007-9327/full/v31/i6/101163.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i6.101163